Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$15.48
-3.37%today
MKT CAP
$1.3B
-0.1% · 1Y
Earnings History
-5.5%
+11.1%
-13.2%
+2.2%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$15.48
Low
$27.00
Analyst Mean
$33.33
High
$42.00
6 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-27.3x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-32.6%
Debt / Equity1.53x
Free Cash Flow$-46,856,876
Insider Ownership3.5%
Institutional Ownership61.5%
Short % of Float22.88%
Days to Cover14.0d
1 Week-1.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | 1,176,332 | $4.16 | $4.89M | 2025-06-27 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Conversion | 1,397,684 | $3.50 | $4.89M | 2025-06-27 |
| THOMPSON PETER A | Director and Beneficial Owner of more than 10% of a Class of Security | Sale | 1,176,332 | $4.16 | $4.89M | 2025-06-27 |
| THOMPSON PETER A | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion | 1,397,684 | $3.50 | $4.89M | 2025-06-27 |
| JONES WILLIAM BENTON | Officer | Conversion | 19,357 | $3.50 | $0.07M | 2025-06-04 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Orbimed Advisors LLC. | institution | 8.52% | $0.11B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 6.01% | $0.08B | +7.34% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.61% | $0.06B | +11.57% | 2025-12-31 |
| Morgan Stanley | institution | 4.24% | $0.06B | +478.06% | 2025-12-31 |
| Adams Street Partners, LLC | institution | 3.90% | $0.05B | +0.00% | 2025-12-31 |
| Point72 Asset Management, L.P. | institution | 3.42% | $0.04B | -55.46% | 2025-12-31 |
| State Street Corporation | institution | 3.32% | $0.04B | +177.07% | 2025-12-31 |
| MPM Bioimpact LLC | institution | 3.26% | $0.04B | +100.00% | 2025-12-31 |
| Vivo Capital, LLC | institution | 2.66% | $0.03B | +0.00% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 2.63% | $0.03B | +33.43% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.37% | $0.03B | +4.10% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.85% | $0.02B | +11.81% | 2026-03-31 |
| Geode Capital Management, LLC | institution | 1.75% | $0.02B | +1.13% | 2025-12-31 |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | fund | 0.88% | $0.01B | +100.00% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.84% | $0.01B | -0.86% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.67% | $0.01B | +0.62% | 2026-02-28 |
| iShares Trust-iShares Russell 2000 Growth ETF | fund | 0.63% | $0.01B | +10.10% | 2026-03-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.56% | $0.01B | +0.21% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.45% | $0.01B | +0.12% | 2026-02-28 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | fund | 0.34% | $0.00B | -2.49% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for CRVS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.